Skip to main content
Fig. 10 | Cancer Nanotechnology

Fig. 10

From: Preparation and characterization of cetuximab-loaded egg serum albumin nanoparticles and their uses as a drug delivery system against Caco-2 colon cancer cells

Fig. 10

A Cell cycle analysis data in Caco-2 cells with different treatments showing average percentage numbers of cells at G0/1, S, and G2/M stages of cell cycle. *: significance at P ≤ 0.01, and *: significance at P ≤ 0.001. Flow cytometry histograms for cell cycle: B untreated control, C pure albumin, D free CET, E ESA-NPs, F CET-ANPs, and G CET + ESA-NPs combination

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us